Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.71ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used